Immunogenicity, the ability of a substance to provoke an immune response23, was a key concern of regulators and healthcare professionals when the first biosimilars were approved over a decade ago. Verifying that the proposed biosimilar and reference product have comparable immunogenicity profiles, via a head-to-head comparison, is a critical component in defining the safety profile … Continue reading Immunogenicity